Vertex Pharmaceuticals Inc (VRTX) — Analysis Summary
Vertex Pharmaceuticals Inc (VRTX) has a market cap of $113.59B with year-over-year revenue growth of +8.9%. Net margin stands at 32.9%. The stock trades at a P/E ratio of 26.2.
Key Takeaways
- Revenue changed +8.9% year-over-year
- Net margin of 32.9%
- P/E ratio of 26.2
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, VRTX posted revenue growth of +8.9% and trades at a P/E of 26.2.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.